{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "exchangeTimezoneName": "Asia/Kolkata", "exchangeTimezoneShortName": "IST", "currency": "INR", "market": "in_market", "esgPopulated": false, "gmtOffSetMilliseconds": 19800000, "exchange": "NSI", "longName": "Aurobindo Pharma Limited", "shortName": "AUROBINDO PHARMA", "regularMarketPrice": 609.2, "regularMarketChangePercent": 0.4617394, "messageBoardId": "finmb_1514127", "marketState": "CLOSED", "fiftyTwoWeekHighChangePercent": -0.023013351, "fiftyTwoWeekLow": 397.2, "fiftyTwoWeekHigh": 623.55, "earningsTimestamp": 1675998000, "earningsTimestampStart": 1675998000, "earningsTimestampEnd": 1675998000, "trailingAnnualDividendRate": 7.5, "trailingPE": 17.740246, "trailingAnnualDividendYield": 0.012368074, "fiftyTwoWeekLowChange": 212.0, "fiftyTwoWeekLowChangePercent": 0.5337361, "fiftyTwoWeekRange": "397.2 - 623.55", "fiftyTwoWeekHighChange": -14.349976, "epsTrailingTwelveMonths": 34.34, "epsForward": 62.29, "epsCurrentYear": 55.77, "priceEpsCurrentYear": 10.923435, "sharesOutstanding": 585939008, "bookValue": 435.807, "fiftyDayAverage": 541.051, "fiftyDayAverageChange": 68.14899, "fiftyDayAverageChangePercent": 0.12595667, "twoHundredDayAverage": 504.20325, "twoHundredDayAverageChange": 104.996765, "twoHundredDayAverageChangePercent": 0.20824294, "marketCap": 356954046464, "forwardPE": 9.780061, "priceToBook": 1.3978665, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "averageAnalystRating": "1.9 - Buy", "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 821677500000, "priceHint": 2, "regularMarketChange": 2.7999878, "regularMarketTime": 1683885596, "regularMarketDayHigh": 614.35, "regularMarketDayRange": "599.05 - 614.35", "regularMarketDayLow": 599.05, "regularMarketVolume": 905895, "regularMarketPreviousClose": 606.4, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "fullExchangeName": "NSE", "financialCurrency": "INR", "regularMarketOpen": 608.7, "averageDailyVolume3Month": 1767841, "averageDailyVolume10Day": 953253, "symbol": "AUROPHARMA.NS"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Galaxy, Plot No. 1", "address2": "22nd-24th Floor Plot No.1, Survey No.83/1 Hyderabad Knowledge City,Raidurg Panmakt", "city": "Hyderabad", "zip": "500032", "country": "India", "phone": "91 40 6672 5000", "fax": "91 40 2374 1080", "website": "https://www.aurobindo.com", "industry": "Drug Manufacturers\u2014Specialty & Generic", "industryDisp": "Drug Manufacturers\u2014Specialty & Generic", "sector": "Healthcare", "longBusinessSummary": "Aurobindo Pharma Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients, generic pharmaceuticals, and related services in India. The company primarily offers oral solids, injectables, and over-the-counter drugs, as well as active pharmaceutical ingredients and finished dosage forms for cardiovascular, central nervous system, gastroenterology, anti-allergies, anti-diabetics, anti-retroviral, antibiotics, dermatology, respiratory, and oncology. It is also involved in the development of a product pipeline in biosimilar and vaccine segments; and custom research and manufacturing activities for the bio-tech and pharmaceutical community. In addition, the company develops and manufactures peptides, as well as biocatalysts for use in the pharmaceutical and chemical industries. Further, it is developing biosimilar, inhalers, transdermal patches, vaccines, topicals, and depot injections. The company also exports its products. It serves multinational companies. The company has an agreement with COVAXX to develop and commercialize COVID-19 Vaccine for India and UNICEF. Aurobindo Pharma Limited was incorporated in 1986 and is headquartered in Hyderabad, India.", "fullTimeEmployees": 15431, "companyOfficers": [{"maxAge": 1, "name": "Mr. Kambam Nityananda Reddy", "age": 64, "title": "Vice Chairman & MD", "yearBorn": 1958, "fiscalYear": 2022, "totalPay": {"raw": 27198911, "fmt": "27.2M", "longFmt": "27,198,911"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Meenakshi Sunderam Sivakumaran", "age": 79, "title": "Whole-Time Director", "yearBorn": 1943, "fiscalYear": 2022, "totalPay": {"raw": 23320100, "fmt": "23.32M", "longFmt": "23,320,100"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Mettu Madan Mohan Reddy", "age": 62, "title": "Whole-Time Director", "yearBorn": 1960, "fiscalYear": 2022, "totalPay": {"raw": 52347922, "fmt": "52.35M", "longFmt": "52,347,922"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Santhanam  Subramanian", "age": 61, "title": "Chief Financial Officer", "yearBorn": 1961, "fiscalYear": 2020, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Sanjeev Indravadan Dani", "age": 62, "title": "COO & Head of Formulations", "yearBorn": 1960, "fiscalYear": 2018, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. S. Vijaya Kumar", "age": 56, "title": "Pres of Technical", "yearBorn": 1966, "fiscalYear": 2018, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Arvind  Bothra", "title": "Head of Investor Relations & Corp. Communications", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. B. Adi Reddy", "title": "Compliance Officer & Company Sec.", "fiscalYear": 2020, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. G. P. Prasad", "title": "Sr. VP of Global Fin. & Operations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Sudhir Bimal Singhi", "age": 53, "title": "Head of Global Fin. Operations", "yearBorn": 1969, "fiscalYear": 2018, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 10, "boardRisk": 4, "compensationRisk": 1, "shareHolderRightsRisk": 1, "overallRisk": 4, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}